FDA authorizes Pfizer's Covid omicron booster as fourth shot for kids under 5
Publishing timestamp: 2023-03-14 18:07:02
Summary
The FDA has authorized Pfizer's omicron booster shot for children aged six months to four years old who have previously received three doses of the company's original vaccine. The new bivalent shot targets both the original Covid strain and omicron BA.4 and BA.5. The decision aims to better protect young children after a winter season that saw hospitals overwhelmed with respiratory illnesses, including Covid, RSV, and flu. The authorization is based on clinical trial data from 60 children in the age group who previously received three doses of Pfizer's original vaccine and were given one dose of the company's new booster.
Sentiment: NEUTRAL
Keywords: pfizer inc, health care industry, business news, biotechnology, pharmaceuticals, breaking news: business, moderna inc, biontech se, breaking news, biotech and pharmaceuticals,